Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LogicBio Therapeutics, Inc. | Chief Medical Officer | Common Stock | 0 | $2.01 | Nov 16, 2022 | Direct | |
LogicBio Therapeutics, Inc. | Chief Medical Officer | Stock Option (right to buy) | 0 | Nov 16, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LOGC | LogicBio Therapeutics, Inc. | Nov 16, 2022 | 2 | $0 | 4 | Nov 17, 2022 | Chief Medical Officer |
LOGC | LogicBio Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 3, 2022 | Chief Medical Officer |
LOGC | LogicBio Therapeutics, Inc. | Aug 6, 2021 | 3 | -$6.38K | 4 | Aug 10, 2021 | Chief Medical Officer |
LOGC | LogicBio Therapeutics, Inc. | May 19, 2021 | 1 | $0 | 4 | May 20, 2021 | Chief Medical Officer |
LOGC | LogicBio Therapeutics, Inc. | May 19, 2021 | 0 | $0 | 3 | May 20, 2021 | Chief Medical Officer |